Latest filingSep 02, 2026Most recent Form 4
DCOY
Decoy Therapeutics Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$010 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period10transactions
- A · Grants / awards · dominant10 · 100%
Activity by reported role
A joint filing can contribute to multiple roles10transactions
- Director · dominant6 · 60%
- CBO1 · 10%
- Chief executive officer1 · 10%
- Chief financial officer1 · 10%
- CSO1 · 10%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (10)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeGauthier Patricia G.Common Stock · Direct
2,000Aug 31, 2026
McVicar William K.Common Stock · Direct
3,002Aug 31, 2026
Burleson TessCommon Stock · Direct
2,002Aug 31, 2026
Lammers PaulCommon Stock · Direct
2,001Aug 31, 2026
Hanish Arnold CCommon Stock · Direct
3,418Aug 31, 2026
Hibner Barbara LouiseCommon Stock · Direct
4,216Aug 31, 2026
Rosenblum Mark JCommon Stock · Direct
11,363Aug 31, 2026
Marschel Peter KlausCommon Stock · Direct
3,900Aug 31, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
DCOY transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Decoy Therapeutics Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Decoy Therapeutics Inc.?
Lieber Jonathan I, PIERCE FREDERICK II, Marschel Peter Klaus, Rosenblum Mark J, Hibner Barbara Louise, HANISH ARNOLD C, Lammers Paul, Burleson Tess, McVicar William K., Gauthier Patricia G..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.